AIM
SGRY icon

Acrospire Investment Management’s Surgery Partners SGRY Stock Holding History

Acrospire Investment Management’s Portfolio SGRY Stock Details SGRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-2,254
Closed -$51K – 1191
2017
Q2 		$51K Sell
2,254
-2,053
-48% -$42.2K 0.05% 837
2017
Q1 		$84K Sell
4,307
-6,120
-59% -$119K 0.07% 448
2016
Q4 		$165K Buy
10,427
+4,127
+66% +$68.6K 0.07% 517
2016
Q3 		$128K Sell
6,300
-800
-11% -$14.7K 0.09% 364
2016
Q2 		$127K Buy
7,100
+6,400
+914% +$95.2K 0.09% 282
2016
Q1 		$9K Buy
+700
New +$10.8K 0.01% 1773

Other funds holding SGRY

BCI
Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return
NIPH
NN Investment Partners Holdings The Hague, Netherlands $18.6B AUM 18.31% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AAM
AMI Asset Management Los Angeles, California $1.74B AUM 26.89% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Acrospire Investment Management's SGRY Position: Q3 2017 in Review

Acrospire Investment Management sold out of Surgery Partners (SGRY) in Q3 2017, closing a stake of 2,254 shares — an estimated $51K sold.

Acrospire Investment Management first reported a position in SGRY in Q1 2016 and held it in 6 quarters. The position peaked at $165K in Q4 2016. 90 funds tracked by Wall St. Rank hold SGRY as of Q3 2017.

  • Acrospire Investment Management reported no remaining Surgery Partners position as of Q3 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 2,254 Surgery Partners shares in Q3 2017, an estimated $51K.
  • Acrospire Investment Management first reported a position in Surgery Partners in Q1 2016 and held it in 6 quarters.
  • Acrospire Investment Management's Surgery Partners position peaked at $165K in Q4 2016.
  • 90 funds tracked by Wall St. Rank held Surgery Partners as of Q3 2017.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.